Single and combination nonhormonal chemotherapy in breast cancer
β Scribed by Stephen K. Carter
- Publisher
- John Wiley and Sons
- Year
- 1972
- Tongue
- English
- Weight
- 903 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Seventyβtwo women with metastatic breast cancer were treated with multipleβagent chemotherapy. Fifty women were treated with 5 drugs in combination: 5βFU, methotrexate, vincristine, cytoxan, and prednisone; 22 were treated with the combination of 3 drugs: 5βFU, cytoxan, and prednisone.
Single a n d combination chemotherapy was evaluated for antitumor activity against N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT)-induced bladder carcinoma in syngeneic mice.
## Abstract The outcome in 254 patients with all stages of breast cancer treated by combination chemotherapy is presented. All the patients were treated 10 ormore years ago. The 10-year survival rate for Stages, and II corrt bined is 60 per cent, in Stage III 19 per cent and in Stage IV 3 per cent.